Compare Immunovant Inc. Common Stock (IMVT) vs PT Telekomunikasi Indonesia Tbk (TLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs PT Telekomunikasi Indonesia Tbk — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while PT Telekomunikasi Indonesia Tbk trades at $12.86 (market cap $12.75B). The key difference: PT Telekomunikasi Indonesia Tbk is the larger of the two by market cap, and PT Telekomunikasi Indonesia Tbk pays a 9.37% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and PT Telekomunikasi Indonesia Tbk for 0 Days on average.
| IMVT | TLK | |
|---|---|---|
Market Cap | $6.62B | $12.75B |
Volume | 1,131,364 | 1,019,905 |
Sector | Health | Media |
52-Week High | $44.96 | $23.43 |
52-Week Low | $17.03 | $12.42 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.72B | $14.11B |
Dividend Yield | — | 9.37% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About PT Telekomunikasi Indonesia Tbk
Telkom Indonesia provides mobile, fixed-line, broadband, and digital services in Indonesia. Its businesses include Telkomsel, which serves the country’s mobile market.
Read more on TLK →
